SEC Form 3 · accession 0001415889-18-000685
Medite Cancer Diagnostics, Inc. · MDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel S Kanter
Director
Period of report
Nov 12, 2017
Accepted (ET)
May 4, 2018 · 2:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075439
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 139,424 | I | VOTING CONTROL AS PRESIDENT AND DIRECTOR OF NON-PROFIT CORPORATION | |
| Common Stock | holding | — | — | — | 200,000 | I | BENEFICIARY OF TRUST/NO VOTING CONTROL |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.50 | holding | — | — | — | Jun 29, 2017 | Jun 28, 2022 | Common Stock | 50,000 | — | I |
| Warrants | $0.50 | holding | — | — | — | Jun 30, 2017 | Jun 29, 2022 | Common Stock | 100,000 | — | I |
| Warrants | $0.60 | holding | — | — | — | Mar 27, 2018 | Sep 26, 2022 | Common Stock | 19,724 | — | I |